美托洛尔治疗慢性充血性心理衰竭76例临床体会
摘要
随着慢性充血性心力衰竭的治疗,由经典的的“强心利尿,扩血管”转为改变衰竭心脏的生物学物质的修复性策略的治疗,
二级参考文献12
-
1Colucci WS,Packer M,Bristow MR,et al.Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure[].Circulation.1996
-
2Bristow MR,Gilbert EM,Abraham WT,et al.Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure[].Circulation.1996
-
3Whorlow SL,Krum H.Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure[].The American Journal of Cardiology.2000
-
4Teerlink JR,Massie BM.Beta-adrenergic blocker mortality trials in congestive heart failure[].The American Journal of Cardiology.1999
-
5Waagestein F,Bristow MR,Swedberg K,et al.Beneficial effect of metoprolol in idiopathic dilated cardiomyopathy[].The Lancet.1993
-
6The Beta-Blocker Evaluation of Survival Trial Investigators.A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure[].The New England Journal of Medicine.2001
-
7CIBIS Investigators and Committees.A randomized trial ofβ-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study ( CIBIS )[].Circulation.1994
-
8Packer M,Coats AJS,Fowler MB,et al.Effect of carvedilol on survival in severe chronic heart failure[].The New England Journal of Medicine.2001
-
9CIBIS-II Investigators and Committees.The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial[].The Lancet.1999
-
10Packer M,Colucci WS,Sackner-Bernstein JD,et al.Double-blind,placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure.The PRECISE Trial[].Circulation.1996
共引文献335
-
1李荣德.β1受体阻滞剂运用于慢性肺心病心功能不全患者的疗效及安全性评价[J].医学信息(医学与计算机应用),2014,0(25):289-290.
-
2刘品发.β受体阻滞剂在心力衰竭中的应用[J].青海医药杂志,2007,37(5):92-94. 被引量:4
-
3李艳芳.美托洛尔治疗慢性充血性心力衰竭临床观察[J].实用医技杂志,2008,15(14):1828-1829.
-
4姚丽红,杨革军.β受体阻滞剂在慢性心衰治疗中的应用观点[J].现代保健(医学创新研究),2006(7).
-
5赵书平.依那普利与比索洛尔联用治疗充血性心力衰竭疗效观察[J].青海医药杂志,2008,38(6):14-16.
-
6李锋.倍他乐克治疗慢性心力衰竭的初期反应[J].河北医学,2004,10(12):1092-1094.
-
7刘建平,崔步云,王亚伟.加用β受体阻滞剂抗心力衰竭的体会[J].山西医科大学学报,2003,34(S1):19-20.
-
8龙章林.氨酰心胺治疗慢性心力衰竭的临床观察[J].中国医师杂志,2002,4(S1).
-
9杨铁勇,李霞.倍他乐克治疗充血性心力衰竭临床观察[J].兵团医学,2008(2):6-7.
-
10贾安琪,韩奇,张春泉.抗高血压药物的循证发展[J].杭州医学高等专科学校学报,2004,25(4):182-184.
-
1廖开历.慢性充血性心力衰竭药物治疗的临床疗效分析[J].中国医药科学,2011,1(24):83-83.
-
2李叶红.卡托普利联合螺内酯治疗慢性充血性心力衰竭35例疗效观察[J].昆明医学院学报,2010,31(2):113-115. 被引量:2
-
3王欣,历明慧.倍他乐克治疗慢性充血性心力衰竭80例疗效观察[J].健康必读(下),2011(7):346-346.
-
4韦嘉旺,沈敬鸿.中西医结合治疗85例慢性充血性心力衰竭[J].中国医学工程,2015,23(1):101-102.
-
5张宁,周玲玲,岳媛媛.非洛地平治疗慢性充血性心力衰竭的临床疗效分析[J].中国农村卫生,2016,8(04X):24-24. 被引量:4
-
6张俐虹,华永平.卡维地洛治疗慢性心力衰竭的疗效观察[J].中国实用医药,2010,5(36):152-153. 被引量:1
-
7朱大林,彭仁秀,王晋明.心肌纤维化与肾素血管紧张素醛固酮系统[J].现代诊断与治疗,2001,12(1):21-23. 被引量:1
-
8刘学会,樊光辉.中医药对慢性心衰神经内分泌和细胞因子影响的研究概述[J].中西医结合心脑血管病杂志,2013,11(7):853-854. 被引量:14
-
9王学兴.非洛地平治疗慢性充血性心力衰竭的临床疗效分析[J].医学美学美容(中旬刊),2013,22(9):107-108.
-
10李含蓄.螺内酯在慢性充血性心力衰竭治疗中的应用[J].当代医学,2017,23(8):120-121. 被引量:2